Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Other Non-Current Assets (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Other Non-Current Assets data on record, last reported at $305000.0 in Q3 2022.

  • For Q3 2022, Other Non-Current Assets fell 42.67% year-over-year to $305000.0; the TTM value through Sep 2022 reached $305000.0, down 42.67%, while the annual FY2021 figure was $305000.0, 185.05% up from the prior year.
  • Other Non-Current Assets reached $305000.0 in Q3 2022 per AVIR's latest filing, roughly flat from $305000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.6 million in Q3 2020 and bottomed at $107000.0 in Q4 2020.
  • Average Other Non-Current Assets over 3 years is $413000.0, with a median of $305000.0 recorded in 2021.
  • The widest YoY moves for Other Non-Current Assets: up 185.05% in 2021, down 67.64% in 2021.
  • A 3-year view of Other Non-Current Assets shows it stood at $107000.0 in 2020, then skyrocketed by 185.05% to $305000.0 in 2021, then changed by 0.0% to $305000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $305000.0 in Q3 2022, $305000.0 in Q2 2022, and $305000.0 in Q1 2022.